FDA
GAO Report Highlights Ambiguities in DEA and FDA Drug Scheduling Decisions
A Government Accountability Office report notes that the criteria used by the DEA and FDA to place substances in controlled‑substance schedules are not clearly defined in the Controlled Substances Act, leading to…
1 source36 claims checked1d ago
33 unverifiable3 mostly supported
Biblical perspectiveUNHOLY / UNRIGHTEOUS
Full analysis